11 June 2020

Economic analysis of the prevalence and clinical and economic burden of medication error in England

Economic analysis of the prevalence and clinical and economic burden of medication error in England
BMJ Quality & Safety 11 June 2020. doi: 10.1136/bmjqs-2019-010206
  • Researchers from Manchester Centre for Health Economics have estimated that 237 million medication errors occur at some point in the medication process in England annually, 38.4% occurring in primary care; 72% have little/no potential for harm and 66 million are potentially clinically significant. Prescribing in primary care accounts for 34% of all potentially clinically significant errors. Definitely avoidable adverse drug events are estimated to cost the NHS £98 462 582 per year, consuming 181 626 bed-days, and causing/contributing to 1708 deaths.